Purchase Order 36C24120P0077
- Not listed
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10), awarded a $75,228.11 firm fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on December 18, 2025, for the supply of nuclear medicine radiopharmaceuticals. The contract, which carries an ultimate completion date of December 17, 2028, represents a delivery order under a larger indefinite delivery vehicle established between the VA and Jubilant...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a delivery order valued at $1.49 million on January 5, 2023, for the supply of radiopharmaceuticals to the Veterans Integrated Service Network 8 (VISN 8), a regional healthcare network within the Department of Veterans Affairs. The contract, which was not set aside, carries a firm fixed-price structure with an ultimate completion date of September 30, 2023, and is to be performed in Norcross, Georgia....
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a $71,447.90 firm fixed price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on October 1, 2023, for the supply of nuclear radiopharmaceuticals and medical imaging agents. The contract, which was not set aside, is scheduled for completion by September 30, 2024, with performance occurring in San Francisco, California. Jubilant Radiopharma, a...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a $516,060.56 firm fixed-price delivery order by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs, on March 5, 2025. The contract, which is not set aside for small businesses despite the contractor's small disadvantaged business certification, calls for the supply of radiopharmaceuticals to support nuclear medicine operations at VA medical...
- The Veterans Administration awarded a firm fixed-price delivery order valued at $108,619.89 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on October 1, 2024, for the supply of radiopharmaceuticals to support nuclear medicine procedures at VA facilities in California. The contract, which carries no small business set-aside designation, extends through September 30, 2025, and is funded through Veterans Integrated Service Network 22 (VISN 22), a civilian...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 20, awarded a $110,551.19 firm fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on July 1, 2024, for radiopharmaceuticals to support the Portland Veterans Affairs Medical Center. The contract, which carries no set-aside designation, is scheduled for completion by June 30, 2025, with performance occurring at the vendor's facility in Norcross,...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a $200,000 delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 12 on April 4, 2025. The firm-fixed-price contract, with an ultimate completion date of March 31, 2026, covers the supply of radiopharmaceutical products to support nuclear medicine procedures at VA medical facilities. Performance will be executed in Norcross, Georgia. This award was not designated as...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 22, awarded a firm fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on October 1, 2021, for the supply of Iodine-123 radiopharmaceuticals. This non-set-aside contract carries a ceiling value of $244,599.75 with performance completion targeted for September 30, 2026. The contract supports nuclear medicine diagnostic imaging services at VA medical...
- The U.S. Department of Veterans Affairs (VA) awarded a $150,000.00 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA's Veterans Integrated Service Network (VISN) 10, which covers the supply of specialized...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the provision of radiopharmaceutical products and services from October 1, 2019 to March 31, 2020. The potential value of this award is $128,439.35. Jubilant Radiopharma is a self-certified small disadvantaged business that has received multiple contract vehicles from the VA and Defense Health Agency...
On November 1, 2019, the Veterans Integrated Service Network 1 (VISN 1), a regional network within the Department of Veterans Affairs, awarded a purchase order valued at $470,781 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the procurement of radiopharmaceuticals. The contract, structured as a firm fixed-price purchase order with no set-aside designation, is scheduled for completion by December 31, 2025, and covers the supply and delivery of radiopharmaceutical products to be performed at the contractor's facility in Norcross, Georgia. Jubilant Radiopharma, a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, specializes in manufacturing and distributing nuclear medicine products and medical isotopes essential for diagnostic imaging, PET scans, and cancer treatment. This award represents a task order under Jubilant Radiopharma's broader relationship with the VA, which maintains multiple Indefinite Delivery Contracts and Blanket Purchase Agreements with the company valued up to $39.8 million across various VA regional networks. The company has demonstrated significant capability in supplying critical radiopharmaceutical products, including specialized isotopes such as Gallium 68 Dotatate, iodine I-123, and technetium-99m, to support nuclear medicine services across VA healthcare facilities nationwide. The procurement solicitation was posted on August 11, 2019, with submissions due September 13, 2019.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Diagnostic Imaging Service Radiopharmaceuticals | 36C24119Q0516 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 | Pre-Solicitation 1/1 | 8/11/19, 11:10 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Funding Only Action | $19.0k | 12/5/25 | |
| P00011 | Supplemental Agreement for work within scope | ($27k) | 10/20/25 | |
| P00010 | Exercise an Option | $50.0k | 11/13/24 | |
| P00009 | Funding Only Action | ($19k) | 10/29/24 | |
| P00008 | Exercise an Option | $92.2k | 10/31/23 |